Medikra

Malaysia-based obesity biotech Medikra files and sets terms for a $20 million US IPO February 13, 2026 News Malaysia-based obesity biotech Medikra increases shares offered by 25% ahead of $25 million US IPO Medikra, a Malaysia-based developer of plant-based bioactives... Read more